1 recruiting. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
Follow Metastatic Malignant Nongerminomatous Germ Cell Tumor: new trials by email Literature Review of Metastatic Malignant Nongerminomatous Germ Cell Tumor trials Research Report on Metastatic Malignant Nongerminomatous Germ Cell Tumor
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Testing the Addition of Pedmark to Cisplatin Chemotherapy for Reducing Drug-Induced Ear Damage in Men With Stage II-III Metastatic Testicular Germ Cell Tumors Audiometric Test, Cisplatin, Computed Tomography - Hearing Loss, Metastatic Malignant Germ Cell Tumor | Phase 1 | Recruiting | City of Hope Medical Center | 44 | 2026-02-19 | 2026-04-17 |
Hearing Loss (1) · Seminoma (1) · Testicular Neoplasms (1)
Ear Diseases (1) · Endocrine Gland Neoplasms (1) · Endocrine System Diseases (1) · Genital Diseases (1) · Genital Diseases, Male (1) · Genital Neoplasms, Male (1) · Germinoma (1) · Gonadal Disorders (1) · Hearing Disorders (1) · Male Urogenital Diseases (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms by Site (1) · Neoplasms, Germ Cell and Embryonal (1) · Nervous System Diseases (1)
1,2-diaminocyclohexaneplatinum II citrate (1) · Cisplatin (1) · Hearing (1) · Magnetic Resonance Spectroscopy (1) · Platinum (1) · sodium thiosulfate (1)
City of Hope Medical Center (1)
United States (1)
P30CA033572 (1)